166 related articles for article (PubMed ID: 28865089)
21. Regulation of multidrug resistance proteins by genistein in a hepatocarcinoma cell line: impact on sorafenib cytotoxicity.
Rigalli JP; Ciriaci N; Arias A; Ceballos MP; Villanueva SS; Luquita MG; Mottino AD; Ghanem CI; Catania VA; Ruiz ML
PLoS One; 2015; 10(3):e0119502. PubMed ID: 25781341
[TBL] [Abstract][Full Text] [Related]
22. Venetoclax (ABT-199) Might Act as a Perpetrator in Pharmacokinetic Drug-Drug Interactions.
Weiss J; Gajek T; Köhler BC; Haefeli WE
Pharmaceutics; 2016 Feb; 8(1):. PubMed ID: 26927160
[TBL] [Abstract][Full Text] [Related]
23. Interaction potential of the multitargeted receptor tyrosine kinase inhibitor dovitinib with drug transporters and drug metabolising enzymes assessed in vitro.
Weiss J; Theile D; Dvorak Z; Haefeli WE
Pharmaceutics; 2014 Dec; 6(4):632-50. PubMed ID: 25521244
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of the enantiomers of tamsulosin and tolterodine on P-glycoprotein and cytochrome P450 3A4.
Doricakova A; Theile D; Weiss J; Vrzal R
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):49-59. PubMed ID: 27678410
[TBL] [Abstract][Full Text] [Related]
25. Role of human hepatocyte nuclear factor 4alpha in the expression of drug-metabolizing enzymes and transporters in human hepatocytes assessed by use of small interfering RNA.
Kamiyama Y; Matsubara T; Yoshinari K; Nagata K; Kamimura H; Yamazoe Y
Drug Metab Pharmacokinet; 2007 Aug; 22(4):287-98. PubMed ID: 17827783
[TBL] [Abstract][Full Text] [Related]
26. In vitro assessment of drug-drug interaction potential of boceprevir associated with drug metabolizing enzymes and transporters.
Chu X; Cai X; Cui D; Tang C; Ghosal A; Chan G; Green MD; Kuo Y; Liang Y; Maciolek CM; Palamanda J; Evers R; Prueksaritanont T
Drug Metab Dispos; 2013 Mar; 41(3):668-81. PubMed ID: 23293300
[TBL] [Abstract][Full Text] [Related]
27. The androgen receptor antagonist enzalutamide induces apoptosis, dysregulates the heat shock protein system, and diminishes the androgen receptor and estrogen receptor β1 expression in prostate cancer cells.
Abazid A; Martin B; Choinowski A; McNeill RV; Brandenburg LO; Ziegler P; Zimmermann U; Burchardt M; Erb H; Stope MB
J Cell Biochem; 2019 Oct; 120(10):16711-16722. PubMed ID: 31297844
[TBL] [Abstract][Full Text] [Related]
28. Desmethyl bosentan displays a similar in vitro interaction profile as bosentan.
Weiss J; Baumann S; Theile D; Haefeli WE
Pulm Pharmacol Ther; 2015 Feb; 30():80-6. PubMed ID: 25535031
[TBL] [Abstract][Full Text] [Related]
29.
Bleasby K; Fillgrove KL; Houle R; Lu B; Palamanda J; Newton DJ; Lin M; Chan GH; Sanchez RI
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745395
[TBL] [Abstract][Full Text] [Related]
30. The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide.
Del Re M; Fogli S; Derosa L; Massari F; De Souza P; Crucitta S; Bracarda S; Santini D; Danesi R
Cancer Treat Rev; 2017 Apr; 55():71-82. PubMed ID: 28340451
[TBL] [Abstract][Full Text] [Related]
31. Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters.
Weiss J; Bajraktari-Sylejmani G; Haefeli WE
Pharmaceutics; 2020 Sep; 12(10):. PubMed ID: 32992777
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic interaction profile of riociguat, a new soluble guanylate cyclase stimulator, in vitro.
Rickert V; Haefeli WE; Weiss J
Pulm Pharmacol Ther; 2014 Aug; 28(2):130-7. PubMed ID: 24657506
[TBL] [Abstract][Full Text] [Related]
33. Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps.
Burger H; van Tol H; Brok M; Wiemer EA; de Bruijn EA; Guetens G; de Boeck G; Sparreboom A; Verweij J; Nooter K
Cancer Biol Ther; 2005 Jul; 4(7):747-52. PubMed ID: 15970668
[TBL] [Abstract][Full Text] [Related]
34. Brain Accumulation of Ponatinib and Its Active Metabolite, N-Desmethyl Ponatinib, Is Limited by P-Glycoprotein (P-GP/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2).
Kort A; van Hoppe S; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
Mol Pharm; 2017 Oct; 14(10):3258-3268. PubMed ID: 28880088
[TBL] [Abstract][Full Text] [Related]
35. Shikonin upregulates the expression of drug-metabolizing enzymes and drug transporters in primary rat hepatocytes.
Huang CS; Chen HW; Lin TY; Lin AH; Lii CK
J Ethnopharmacol; 2018 Apr; 216():18-25. PubMed ID: 29414119
[TBL] [Abstract][Full Text] [Related]
36. Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer.
van Soest RJ; van Royen ME; de Morrée ES; Moll JM; Teubel W; Wiemer EA; Mathijssen RH; de Wit R; van Weerden WM
Eur J Cancer; 2013 Dec; 49(18):3821-30. PubMed ID: 24200698
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR.
Nishimura M; Yoshitsugu H; Naito S; Hiraoka I
Yakugaku Zasshi; 2002 May; 122(5):339-61. PubMed ID: 12040753
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer.
Shiota M; Yokomizo A; Takeuchi A; Itsumi M; Imada K; Kashiwagi E; Inokuchi J; Tatsugami K; Uchiumi T; Naito S
Prostate; 2014 Jun; 74(9):959-69. PubMed ID: 24740858
[TBL] [Abstract][Full Text] [Related]
39. The role of pregnane X receptor in 2-acetylaminofluorene-mediated induction of drug transport and -metabolizing enzymes in mice.
Anapolsky A; Teng S; Dixit S; Piquette-Miller M
Drug Metab Dispos; 2006 Mar; 34(3):405-9. PubMed ID: 16381673
[TBL] [Abstract][Full Text] [Related]
40. Differential modulation of the expression of important drug metabolising enzymes and transporters by endothelin-1 receptor antagonists ambrisentan and bosentan in vitro.
Weiss J; Herzog M; Haefeli WE
Eur J Pharmacol; 2011 Jun; 660(2-3):298-304. PubMed ID: 21501604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]